Medtech Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

VENTRITEX CADENCE 110 IS APPROVABLE

This article was originally published in The Gray Sheet

Executive Summary

VENTRITEX CADENCE 110 IS APPROVABLE, company President and CEO Frank Fischer announced at a May 12 session of the Alex. Brown annual Health Care Seminar in Baltimore. The firm received the approvable letter from FDA in April, and expects final approval of the implantable cardioverter defibrillator in the third quarter. A premarket approval application supplement for the device was submitted in mid-October.
Advertisement
Advertisement
UsernamePublicRestriction

Register

MT002317

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel